Multicenter Evaluation of Neoadjuvant and Induction Gemcitabine–carboplatin Versus Gemcitabine–cisplatin Followed by Radical Cystectomy for Muscle-Invasive Bladder Cancer | AMiner
Multicenter Evaluation of Neoadjuvant and Induction Gemcitabine–carboplatin Versus Gemcitabine–cisplatin Followed by Radical Cystectomy for Muscle-Invasive Bladder Cancer
Cisplatin-based chemotherapy followed by radical cystectomy (RC) is recommended in patients with muscle-invasive bladder cancer (MIBC). However, up to 50
更多
查看译文
关键词
Bladder,Chemotherapy,Radical cystectomy,Cisplatin,Carboplatin,Neoadjuvant,Urothelial cancer
原文链接
分享
引用
